CLINICAL_TRIALS
trial_result
· 2013-09-16
Clinical Trial Update: Bifeprunox Extension to Extension Study in Patients With Schizophrenia [Phase 3]
Summary
The Phase 3 extension study of bifeprunox in schizophrenia was terminated.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: H. Lundbeck A/S | Conditions: Schizophrenia | Phase 3 | Status: TERMINATED